Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study

Four formulations of an investigational tetravalent dengue purified inactivated vaccine, administered as two doses one month (M) apart, were previously shown to be immunogenic and well-tolerated up to M13 of the phase I study NCT01702857. Here, we report results of the follow-up from M14 to year (Y)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Trop Med Hyg
Main Authors: Diaz, Clemente, Koren, Michael, Lin, Leyi, Martinez, Luis J., Eckels, Kenneth H., Campos, Maribel, Jarman, Richard G., De La Barrera, Rafael, Lepine, Edith, Febo, Irma, Vaughn, David W., Wilson, Todd M., Paris, Robert M., Schmidt, Alexander C., Thomas, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Tropical Medicine and Hygiene 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204593/
https://ncbi.nlm.nih.gov/pubmed/32124728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0461
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados